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Abstract  31 
 32 
               Gamma irradiation is a non-thermal processing technology that has been used for 33 
preservation of varieties of food products. This technology has been shown to effectively 34 
inactivate bacterial pathogens. Currently, the FDA has approved doses of up to 4.0 kGy to 35 
control foodborne pathogens in fresh iceberg lettuce and spinach.  However, whether this dose 36 
range effectively inactivates foodborne viruses is less understood. We have performed a 37 
systematic study on the inactivation of human norovirus surrogate (murine norovirus 1, MNV-1), 38 
human norovirus virus-like particles (VLPs), and vesicular stomatitis virus (VSV) by gamma 39 
irradiation. We demonstrated that MNV-1 and human norovirus VLPs were resistant to gamma 40 
irradiation. For MNV-1, only 1.7-2.4 log virus reduction was observed in fresh produce at the 41 
dose of 5.6 kGy.  However, VSV was more susceptible to gamma irradiation, and a 3.3 log virus 42 
reduction was achieved at a dose of 5.6 kGy in DMEM. We further demonstrated that gamma 43 
irradiation disrupted virion structure, and degraded viral proteins and genomic RNA which 44 
resulted in virus inactivation. Using human norovirus VLPs as a model, we provided first 45 
evidence that the capsid of human norovirus has a similar stability compared to MNV-1 after 46 
exposure to gamma irradiation. Overall, our results suggest that viruses are much more resistant 47 
to irradiation than bacterial pathogens. Although gamma irradiation seems impractical to 48 
eliminate the virus contaminants in fresh produce by the FDA approved irradiation dose limits, 49 
this technology may be practical to inactivate viruses for other purposes such as sterilization of 50 
medical equipment.  51 
 52 
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Introduction 53 
 54 
           Norovirus is a major food and waterborne pathogen that causes acute gastroenteritis in 55 
humans. The virus is primarily transmitted through the fecal-oral route, either by direct contact 56 
with fecal matter or indirect contact through contaminated food or water supplies. It is highly 57 
stable and contagious, requiring less than ten virus particles to cause an infection (20, 35, 44, 58 
51). Recent human volunteer study and mathematical modeling showed that the average 59 
probability of infection for a single norovirus particle to be close to 0.5 (56). Norovirus 60 
outbreaks occur worldwide and have a significant impact in food safety and public health. The 61 
National Institute of Allergy and Infectious Diseases (NIAID) categorized human norovirus as a 62 
Category B priority bio-defense pathogen. Food associated outbreaks occur in diverse locales 63 
including restaurants, nursing homes, schools, cruise ships, and personal residences (1, 15, 21, 64 
25, 31, 43). In fact, it is estimated that over 90% of nonbacterial gastroenteritis is caused by 65 
norovirus infections (21, 35, 43). This may even be an under estimation due to the large number 66 
of unreported or asymptomatic infections (21, 35). The virus has a significant economic and 67 
emotional impact in society; however research on this bio-defense agent has been impeded 68 
because it cannot be cultivated in vitro (19).  69 
            Foods at high risk of norovirus contamination include fresh produce. Norovirus 70 
contamination can occur during pre-harvest and post-harvest stages, such as by contaminated 71 
irrigation water, septic tank runoff, and mishandling by farm workers and food handlers (2, 8, 24, 72 
26, 39, 53). Additionally, fresh produce undergoes minimal to no processing and thus increasing 73 
the viral infection risk (8, 18, 26, 54). In fact, norovirus accounts for more than 40% of fresh 74 
produce associated outbreaks (18). Berries shipped across international borders have also been 75 
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known to cause outbreaks because the virus can remain stable on the frozen tissue (10, 11, 48). 76 
Currently, chlorine-based sanitizers are widely used in the fresh produce industry as the primary 77 
decontamination method for pathogen removal (3, 18). However, it has been demonstrated that 78 
these sanitizers are not effective in removing human norovirus surrogates and hepatitis A virus 79 
from fresh produce (3, 53). Chlorine solution rinses can only achieve a maximum 1-1.5 log virus 80 
reduction in contaminated fresh produce (3, 53). More importantly, recent evidence suggests 81 
noroviruses can become internalized in fresh produce (50, 61, 62). Chemical sanitizers may 82 
reduce the viruses at the surface level of produce, but not those that have been internalized.  83 
            One potential technology to decontaminate the pathogens in fresh produce is irradiation 84 
technology (22, 59). High frequency electromagnetic waves (gamma rays) are released during 85 
isotopic negative beta decay. The decay involves the conversion of a neutron into a proton which 86 
releases an electron and an antineutrino; gamma rays are released during this process (17, 23). 87 
Gamma ray frequencies are in the magnitude of 1019Hz; these high energy electromagnetic 88 
waves may hold potential in disrupting viral pathogens (17, 23). The high energy waves can 89 
penetrate into food products, and thus can potentially inactivate internalized pathogens.  90 
Currently, the FDA has approved doses of up to 4.0 kGy to control foodborne pathogens in fresh 91 
iceberg lettuce and spinach (FDA Regulations, 21 CFR 179.26).  It has been shown that gamma 92 
irradiation effectively inactivated Escherichia coli O157:H7, Listeria monocytogenes, and 93 
Salmonella in food products, including fresh produce, at this approved dose (5, 17, 34, 45, 59).  94 
            However, the feasibility of using gamma irradiation to eliminate human norovirus, the 95 
major causative agent of foodborne illnesses, is not understood. This is due to the fact that 96 
human norovirus lacks a cell culture system (19). Thus, survival studies of human norovirus 97 
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must rely on suitable surrogates such as feline calicivirus (FCV) (16, 60), canine calicivirus 98 
(CaCV) (16), and murine norovirus (MNV-1) (4, 13). It was reported that a 3 log virus reduction 99 
was observed in low protein-content solution at 0.5kGy for FCV and 0.3 kGy for CaCV by 100 
gamma irradiation (16). It seems that these two surrogates were quite susceptible to gamma 101 
irradiation, or at least in low-protein-content solutions. However, no survival trend data have 102 
been reported for any human norovirus surrogates in food samples including fresh produce. More 103 
importantly, recent studies found that MNV-1 is a better surrogate for human norovirus due to 104 
their biochemical, genetic, and morphological similarities (13). For example, the size (35-38 nm 105 
in diameter), shape (icosahedral, small rounded structure), viral capsid, and RNA genome of 106 
MNV-1 are all analogous to human norovirus (32, 63). Furthermore, MNV-1 is highly resistant 107 
to acidic environments and is more stable than FCV (13).  To date, no study has been performed 108 
investigating the susceptibility of MNV-1 to gamma irradiation. Moreover, the mechanism of 109 
viral inactivation by irradiation is poorly understood. Noroviruses and other caliciviruses are 110 
non-enveloped viruses and the outer shell of these viruses possesses a highly stable capsid that 111 
protects their genetic material, the single-stranded positive-sense RNA. The effect of gamma 112 
irradiation on viral capsid and genomic RNA has not been determined.  113 
             In this study, we performed a systematic study on the inactivation of MNV-1 and human 114 
norovirus virus-like particles (VLPs) by gamma irradiation. We also selected vesicular stomatitis 115 
virus (VSV), an enveloped virus, as a comparison since the virion structure of VSV is 116 
significantly different compared to norovirus. Furthermore, we determined the mechanism of 117 
viral inactivation by gamma irradiation. We investigated the effect of gamma irradiation on viral 118 
proteins, genomic RNA, capsid integrity, and virus particles. In addition, we provided first 119 
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evidence that the capsid proteins of human norovirus VLPs and MNV-1 have a similar stability 120 
after exposure to gamma irradiation.  121 
 122 
Materials and Methods 123 
Viruses and cell culture. Murine norovirus strain MNV-1 was generously provided by Dr. 124 
Herbert W. Virgin IV, Washington University School of Medicine (32). Vesicular stomatitis 125 
virus (VSV) Indiana strain was a generous gift from Dr. Sean Whelan at Harvard Medical School 126 
(36, 37).  MNV-1 and VSV were propagated  in confluent monolayers of murine macrophage 127 
cell line RAW 264.7 (ATCC, Manassas, VA) and baby hamster kidney cells (BHK-21 cells), 128 
respectively.  Both RAW 264.7 and BHK-21 cells were cultured in high-glucose Dulbecco’s 129 
modified Eagle medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal 130 
bovine serum (FBS) (Invitrogen), at 37 oC under a 5% CO2 atmosphere. For growing MNV-1 131 
stock, confluent RAW 264.7 cells were infected with MNV-1 at a multiplicity of infection (MOI) 132 
of 0.01. After 1 h incubation at 37 oC, 15 ml of DMEM supplemented with 2% FBS was added. 133 
The virus was harvested after 2 days post inoculation by three freeze-thaw cycles and low speed 134 
centrifugation at 15,000 rpm for 30 min. Preparation of VSV stock was performed as described 135 
previously. Briefly, confluent BHK-21 cells were infected with VSV at a MOI of 3. After 1 h 136 
incubation at 37 oC, 15 ml of DMEM supplemented with 2% FBS was added. Virus was 137 
harvested after 18 h post inoculation by low speed centrifugation at 5,000 rpm for 10 min.  138 
 139 
Sample preparation and gamma irradiation. Fresh produce (strawberry, romaine lettuce, and 140 
spinach) was purchased from a local supermarket. One ml of MNV-1 virus stock (108 PFU/ml) 141 
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was inoculated into 10 g of each produce to achieve an inoculation level of 107 PFU/g. Samples 142 
were prepared in triplicates. The samples were heat sealed in plastic compartments using an AIE-143 
200 Impulse Sealer (American International Electric, Whittier, CA) and mixed thoroughly on a 144 
shaker for 30 min. All samples were stored in an ice box and delivered to the Nuclear Reactor 145 
Laboratory (NRL) at The Ohio State University. Irradiation treatment took place in a 6 in 146 
diameter cylinder in the NRL Cobalt-60 irradiator. Samples were irradiated at doses of 147 
0.175kGy, 0.35kGy, 0.525kGy, 0.7kGy, 2.8kGy, 5.6kGy, 11.2kGy, 16.8kGy, and 22.4kGy. 148 
After treatment, 5 ml of phosphate-buffered saline (PBS, 137 mM NaCl, 10 mM Na2HPO4, 2 149 
mM NaH2PO4, pH 7.4) were added to each bag, and the samples were  stomached for 2 min. 150 
Virus was eluted by low speed centrifugation at 5,000 rpm for 10 min. The sensitivity of VSV 151 
and MNV-1 to irradiation in DMEM was also tested. One ml of MNV-1 (108 PFU/ml) and VSV 152 
(109 PFU/ml) stocks were inoculated into 10 ml of DMEM to achieve an inoculation level of 107 153 
PFU/ml and 108 PFU/ml, respectively. To study the mechanism of viral inactivation, 20 µg of 154 
highly purified MNV-1 and VSV (1 µg /µl) were prepared for gamma irradiation. All samples 155 
were heat sealed in plastic compartments and irradiated for 2.8kGy, 5.6kGy, 11.2kGy, 16.8kGy, 156 
and 22.4kGy. The viral survivors were determined by plaque assay.  157 
 158 
MNV-1 and VSV plaque assay. MNV-1 and VSV plaque assay were performed in RAW 264.7 159 
and Vero cells, respectively. Briefly, cells were seeded  into six-well plates (Corning Life 160 
Sciences, Wilkes-Barre, PA) at a density of 2 × 106 cells per well. After 24 h incubation, RAW 161 
264.7 and Vero cell monolayers were infected with 400 µl of a 10-fold dilution series of MNV-1 162 
or VSV, respectively, and the plates were incubated for 1 h at 37oC with agitation every 10 min. 163 
The cells were overlaid with 3 ml of Eagle minimum essential medium (MEM) containing 1% 164 
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agarose, 2% FBS, 1% sodium bicarbonate,  0.1 mg of kanamycin/ml, 0.05 mg of gentamicin/ml , 165 
15 mM HEPES (pH 7.7), and 2 mM L-glutamine. After incubation at 37 °C and 5% CO2 for 24 166 
h, the plates were fixed in 10% formaldehyde and the plaques were visualized by staining with 167 
0.05% (w/v) crystal violet. 168 
 169 
Purification of MNV-1 and VSV. To grow a large stock of MNV-1, 18 confluent T150 flasks 170 
of RAW 267.1 cells were infected with MNV-1 at a MOI of 0.01 in a volume of 3 ml of DMEM. 171 
At 1 h post-absorption, 15 ml of DMEM with 2% FBS was added to the flasks, and infected cells 172 
were incubated at 37°C for 48 h. When extensive cytopathic effect (CPE) was observed, cell 173 
culture fluid was harvested and subjected to three freeze-thaw cycles to release virus particles. 174 
The purification of MNV-1 was performed using the method described by Katpally et al (2008) 175 
with minor modifications (33). Briefly, virus suspension was centrifuged at 8,000×g for 15 min 176 
to remove cellular debris. The supernatant was digested with DNase I (10 µg/ml) and MgCl2 (5 177 
mM) at room temperature. After 1 h incubation, 10 mM EDTA and 1% lauryl sarcosine were 178 
added to stop nuclease activity. Virus was concentrated by centrifugation at 82,000×g for 6 h at 179 
4°C in a Ty 50.2 rotor (Beckman, Brea, CA). The pellet was resuspended in PBS and further 180 
purified by centrifugation at 175,000 × g for 6 h at 4°C through a sucrose gradient (7.5 to 45%) 181 
in an SW55 Ti rotor (Beckman). The final virus-containing pellets were resuspended in 100 µl 182 
PBS. The virus titer was determined by plaque assay on RAW 264.7 cells. Viral protein was 183 
measured by Bradford reagent (Sigma Chemical Co., St. Louis, MO). The purified virus stock 184 
was diluted at the final concentration of 1 µg/µl. Approximately 1 mg of purified MNV-1 was 185 
obtained.  186 
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            Purification of VSV was performed by the method described in our previous publication 187 
(36, 37). Briefly, 10 confluent T150 flask BHK-21 cells were infected by VSV at a MOI of 0.01. 188 
At 1 h post-absorption, 15 ml of DMEM (supplemented with 2% FBS) was added to the cultures, 189 
and infected cells were incubated at 37°C. After 24 h post-infection, cell culture fluid was 190 
harvested by centrifugation at 3,000 × g for 5 min. Virus was concentrated by centrifugation at 191 
40,000 × g for 90 min at 4°C in a Ty 50.2 rotor. The pellet was resuspended in NTE buffer (100 192 
mM NaCl, 10 mM Tris, 1 mM EDTA [pH 7.4]) and further purified through 10% sucrose NTE 193 
by centrifugation at 150,000 × g for 1 h at 4°C in an SW50.1 rotor. The final pellet was 194 
resuspended in 0.3 ml of NTE buffer. The virus titer was determined by plaque assay on Vero 195 
cells, and the protein content was measured by Bradford reagent (Sigma Chemical Co.). The 196 
purified virus stock was diluted at the final concentration of 1 µg/µl. Approximately 5 mg of 197 
purified MNV-1 was obtained.  198 
 199 
Expression and purification of human norovirus virus-like particles (VLPs). The capsid 200 
VP1 gene of human norovirus G II.4 strain HS66 (GenBank accession no. EU105469, kindly 201 
provided by Dr. Linda Saif, The Ohio State University) was amplified by high fidelity PCR, and 202 
cloned into a pFastBac-Dual expression vector (Invitrogen) at Sma I and Xho I sites under the 203 
control of the p10 promoter.  The resultant plasmid pFastBac-Dual-VP1 was transformed into 204 
DH10Bac competent cells. Baculovirus expressing VP1 protein was generated by transfection of 205 
bacmids into Spodoptera frugiperda (Sf9) cells with a Cell-fectin Transfection kit (Invitrogen), 206 
according to the instructions of the manufacturer. Purification of human norovirus virus-like 207 
particles (VLPs) from insect cells was described in our previous publication (40). Briefly, Sf9 208 
cells were infected with baculovirus at an MOI of 10, the infected Sf9 cells and cell culture 209 
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supernatants were harvested at 6 days post-inoculation. The VLPs were purified from cell culture 210 
supernatants and cell lysates by ultracentrifugation through a 40% (w/v) sucrose cushion, 211 
followed by CsCl isopycnic gradient (0.39 g/cm3) ultracentrifugation. Purified VLPs were 212 
analyzed by SDS-PAGE, Western blot, and electron microscope (EM). The protein concentration 213 
of the VLPs was measured by Bradford reagent (Sigma Chemical Co.).  214 
 215 
Reverse transcription polymerase chain reaction (RT-PCR). Viral genomic RNA was 216 
extracted from MNV-1 and VSV suspensions (either gamma irradiation treated or untreated) 217 
using an RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. 218 
100 µl of unpurified virus suspension (108PFU/ml) or 10 µl of purified virus stock (total viral 219 
protein concentration at 1 µg/µl) was used for RNA extraction. RT-PCR was performed using a 220 
One Step RT-PCR kit (Qiagen). Two primers (5’-ATGAGGATGAGTGATGGCGC-3’ and 5’-221 
TTATTGTTTGAGCATTCGGCC-3’) were designed to target the capsid MNV-1 VP1 gene. 222 
Two primers (5’-ATGTCTGTTACAGTCAAGAG-3’ and 5’-TCATTTGTCAAATTCTGAC-3’) 223 
were designed to target VSV N gene. All the primers were purchased from Sigma. One-step RT-224 
PCR was performed in a 50 µl of reaction containing 400 µM of each dNTP, 0.6 µM of each 225 
primer, 4 µl of RNA template, 5 unit of RNase inhibitor, and 2 µl of RT-PCR Enzyme Mix. The 226 
amplified products were analyzed on 1% agarose gel electrophoresis. 227 
 228 
Analysis of viral proteins by Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 229 
(SDS-PAGE). A total of 20 µl of high purified viruses (viral protein concentration is1 µg/µl and 230 
viral titer is approximately 1011PFU/ml) was treated by gamma irradiation. Two µg of highly 231 
purified MNV-1 and VSV suspensions (either gamma irradiation treated or untreated) were 232 
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analyzed by SDS-PAGE. Samples were boiled for 5 min in loading buffer containing 1% SDS, 233 
2.5% β-mercaptoethanol, 6.25 mM Tris-HCl (pH 6.8) and 5% glycerol, and loaded into 12% 234 
polyacrylamide gel. Viral proteins were visualized by Coomassie blue staining. 235 
 236 
Western Blotting. MNV-1 and VSV virus proteins were separated by 12% SDS-PAGE and 237 
transferred onto a Hybond ECL nitrocellulose membrane (Amersham, Piscataway, NJ) in a Mini 238 
Trans-Blot electrophoretic transfer cell (Bio-Rad, Hercules, CA). For MNV-1, the blot was 239 
probed with rabbit polyclonal MNV-1 antibody (a generous gift from Dr. Virgin) at a dilution of 240 
1:10,000 in blocking buffer (5% skim milk), followed by horseradish peroxidase (HRP)-241 
conjugated goat anti-rabbit IgG secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA) 242 
at a dilution of 1:20,000. Western blot of human norovirus VLPs was essentially identical to 243 
MNV-1 VP1 with the exception of using polyclonal antibody against VP1protein of human 244 
norovirus GII.4 strain (a generous gift from Dr. Xi Jiang, Cincinnati Children's Hospital Medical 245 
Center). For VSV, the blot was probed with mouse monoclonal anti-VSV glycoprotein antibody 246 
(Sigma-Aldrich) at a dilution of 1:5,000 in blocking buffer, followed by incubation with HRP-247 
conjugated anti-mouse IgG secondary antibody at a dilution of 1:100,000. Afterwards, the 248 
membranes were washed three times with PBST + 0.02% Tween for 10 min each time. The blots 249 
were developed with SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, 250 
Pittsburg, PA) and exposed to Kodak BioMax MR film (Kodak, Rochester, NY). 251 
 
252 
Transmission electron microscopy. To determine whether gamma irradiation damages the 253 
virus particles, negative staining electron microscopy of purified virions or human norovirus 254 
VLPs was performed using the method described in our previous publications (38, 40). Briefly, 255 
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20 µl aliquots of either gamma irradiation treated or untreated samples were fixed in copper grids 256 
(Electron Microscopy Sciences, Inc., Hatfield, PA), and negatively stained with 1% ammonium 257 
molybdate. Virus particles were visualized by FEI Tecnai G2 Spirit Transmission Electron 258 
Microscope (TEM) at 80 kV at the Microscopy and Imaging Facility at The Ohio State 259 
University. Images were captured on a MegaView III side-mounted CCD camera (Soft Imaging 260 
System, Lakewood, CO) and figures were processed using Adobe Photoshop software (Adobe 261 
Systems, San Jose, CA). 262 
 263 
Statistical analysis. All experiments were carried out in triplicate. Virus survival was expressed 264 
as mean log titer ± standard deviation. Quantitative analysis was performed by densitometric 265 
scanning of autoradiographs and ImageQuant TL software (GE Healthcare, Piscataway, NJ). 266 
Statistical analysis was performed by one-way multiple comparisons using SPSS 8.0 Statistical 267 
Analysis software (SPSS Inc., Chicago, IL, USA). A value of p<0.05 was considered statistically 268 
significant. 269 
 270 
Results 271 
 272 
Gamma irradiation inactivation of MNV-1 in fresh produce. Using cultivable murine 273 
norovirus as a surrogate, we have now systematically investigated the survival of the virus in 274 
fresh produce after gamma irradiation treatment.  As shown in Fig.1, MNV-1 was gradually 275 
inactivated in fresh produce in a dose-dependent manner. However, MNV-1 is resistant to 276 
gamma irradiation.  At low irradiation doses (0.175kGy, 0.35kGy, 0.525kGy, and 0.7kGy), there 277 
was no significant virus reduction (less than 0.28 log) in all fresh produce samples (P>0.05). At 278 
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dose of 2.8 kGy, only 1.77 log, 1.40 log, and 1.31 log reductions were observed in spinach, 279 
romaine lettuce, and strawberries, respectively. At dose of 5.6 kGy, only 1.7-2.4 log reduction 280 
was observed. Virus inactivation was significantly enhanced at a high dose of gamma irradiation 281 
(P<0.05). At a dose of 11.2 kGy, 3.6-4.1 log virus reductions were achieved in all fresh produce 282 
samples. At a dose of 22.4 kGy, MNV-1 was completely inactivated in romaine lettuce and 283 
strawberry, while 2.4 logs of the virus were detected within the spinach sample.  This suggested 284 
that food matrices may play a role in protecting virus from inactivation. Taken together, these 285 
results demonstrated that MNV-1 was more resistant to gamma irradiation than most bacterial 286 
pathogens. Less than 2 log virus reduction was achieved in all three fresh produce samples at the 287 
FDA approved dose (4kGy). Therefore, it seems impractical to use gamma irradiation as a means 288 
to inactivate virus in fresh produce. 289 
 290 
VSV, an enveloped virus, is more sensitive to gamma irradiation. We compared the stability 291 
of VSV (an enveloped virus) and MNV-1 (a non-enveloped virus) to gamma irradiation. As 292 
shown in Fig.2, VSV was much more sensitive to gamma irradiation than MNV-1. Both VSV 293 
and MNV-1 decreased in virus titer as irradiation dose increased in intensity. However, VSV was 294 
reduced at a greater concentration starting from 5.6kGy. At this dose, a 3.3 log virus reduction 295 
was observed in VSV, while only 1.7 log virus reduction was observed for MNV-1. At the dose 296 
of 16.8kGy, VSV was completely inactivated as confirmed by plaque assays. But, there were still 297 
3.4 log virus survivors of MNV-1.  Actually, an additional 5.6kGy was required to completely 298 
inactive MNV-1.  299 
              We further tested the stability of MNV-1 and VSV in different buffers. Briefly, MNV-1 300 
and VSV were diluted into four different solutions (water, PBS, DMEM and DMEM plus 10% 301 
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FBS) and treated by two different irradiation doses (2.8 and 5.6 kGy), respectively. As shown in 302 
Fig.3A, MNV-1 was stable in all four solutions when treated by gamma irradiation.  There was 303 
no significant difference in virus reduction among these solutions (P>0.05). Approximately less 304 
than 1.0 and 2.0 log virus reductions were achieved at 2.8 and 5.6 kGy, respectively. In sharp 305 
contrast, the stability of VSV in these four solutions was highly different (Fig.3B). Specifically, 306 
VSV was highly susceptible to gamma irradiation when it was diluted in water and PBS. At 2.8 307 
kGy, 2.7 log virus reductions were observed. At 5.6 kGy, 6.3 log virus reductions were observed. 308 
However, when VSV was diluted in DMEM and DMEM plus 10% FBS, only 1.1-2.5 log and 309 
1.3-2.1 log virus reductions were observed at irradiation dose of 2.8 and 5.6 kGy, respectively. 310 
These results demonstrated that the matrix of solution does not affect the stability of MNV-1, but 311 
it has a dramatic impact on the stability of VSV. Again, these data demonstrated that VSV was 312 
much more susceptible to gamma irradiation than MNV-1.  313 
 314 
Gamma irradiation degrades viral proteins. To gain mechanistic insight of viral inactivation, 315 
we selected three specific irradiation doses, 2.8kGy, 5.6kGy, and 22.4kGy. We chose 2.8kGy 316 
and 5.6kGy because less than 1 log and 2.4 log virus reductions were observed, respectively.  A 317 
mixture of infectious and non-infectious virus particles would be present at these two doses. We 318 
chose 22.4kGy because viruses were completely inactivated, which allowed us to precisely 319 
determine what happens to virus particles and viral components when no infectious virus 320 
particles remained.  321 
              It would be lethal to the virus if viral proteins become damaged by gamma irradiation. 322 
The structure of MNV-1 is relatively simple. The surface of MNV-1 possesses a highly stable 323 
viral capsid protein VP1 that surrounds and protects the viral genomic RNA (33, 63). The 324 
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structure of VSV is significantly different with MNV-1. The viral genomic RNA is completely 325 
encapsulated by the nucleocapsid (N) protein, forming the N-RNA complex (36, 37).  In 326 
addition, the viral RNA-dependent RNA polymerase complex (large polymerase protein L and 327 
the phosphoprotein P) is tightly bound to N-RNA which results in the formation of the RNP 328 
complex. This RNP complex is further surrounded by a matrix (M) protein and viral envelope. 329 
The viral glycoprotein (G) is anchored in the envelope. To gain mechanistic insight of viral 330 
inactivation by gamma irradiation, we first determined whether viral proteins were degraded. 331 
Briefly, 20 µg of highly purified MNV-1 and VSV were treated by gamma irradiation at three 332 
different doses: 2.8, 5.6, and 22.4kGy. After treatment, 2 µg of either treated or untreated 333 
samples were analyzed by SDS-PAGE followed by Commassie blue staining. As shown in Fig.4, 334 
the abundance of MNV-1 and VSV proteins gradually decreased when irradiation dose 335 
increased. For MNV-1, the major capsid protein VP1 (molecular weight approximately 58kDa) 336 
was visualized on SDS-PAGE (Fig.4A). After 2.8 and 5.6kGy treatments, the abundance of VP1 337 
proteins decreased to 50% and 30% compared to untreated control, respectively (Fig.4A). At 338 
22.4kGy, the VP1 protein was undetectable by SDS-PAGE analysis, suggesting that MNV-1 339 
VP1 protein was completely degraded (Fig.4B). For VSV, five structural proteins, L, G, P, N and 340 
M, were observed on SDS-PAGE.  However, each viral protein exhibited different sensitivity to 341 
gamma irradiation. VSV polymerase complex (L and P proteins) and G protein were highly 342 
sensitive to gamma irradiation and rapidly degraded after 2.8 and 5.6kGy doses of irradiation 343 
(Fig.4C). These viral proteins were completely degraded after 22.4 kGy treatment (Fig.4D). VSV 344 
M proteins displayed moderate sensitivity. There were approximately 30%, 20% and 5% of M 345 
protein visualized after treatment of 2.8kGy, 5.6kGy, 22.4kGy doses respectively. The N protein 346 
was the most resistant VSV protein to irradiation treatment. There were 45 % and 35% N protein 347 
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detected after 2.8 kGy and 5.6kGy doses, respectively (Fig.4C). Even after 22.4kGy treatment, 348 
there was approximately 25% of N protein remaining (Fig. 4D). In summary, these data clearly 349 
demonstrated that gamma irradiation degraded viral proteins. However, the sensitivity of each 350 
viral protein to irradiation varied. 351 
           Subsequently, we determined whether the remaining proteins from 2.8 and 5.6 kGy 352 
treatments were antigenic.  To address this question, Western blot was performed using antibody 353 
against MNV-1 VP1 or VSV G protein.  As shown in Fig.5, the abundance of MNV-1 VP1 and 354 
VSV G proteins from Western blot essentially correlated with the amount of proteins from 355 
Commassie blue staining. Specifically, 50% and 30% of MNV-1 VP1 protein were detected by 356 
Commassie blue staining after 2.8 and 5.6kGy treatment, respectively. Based on the size of the 357 
bands observed in Western blot, 65% and 40% of MNV-1 VP1 protein were detected (Fig.5A). 358 
For VSV, 15% and 10% of G protein were detected by Commassie blue staining after 2.8 and 359 
5.6kGy treatment (Fig.4C). In Western blot, 20% and 13% of G protein were detected (Fig.5B). 360 
Therefore, these results demonstrated that the undegraded viral proteins still reacted with 361 
monoclonal and polyclonal antibodies and perhaps retained correct primary amino acid 362 
sequences. 363 
 364 
Gamma irradiation damages virus particles. To determine whether gamma irradiation directly 365 
damages the virus particles, we analyzed the virus particles by electron microscopy. For the 366 
untreated control, MNV-1 particles were small spherical structured virions of 30-38 nm in 367 
diameter (Fig.6A). After 2.8 and 5.6kGy irradiation treatment, the number of virus particles was 368 
significantly reduced (Fig. 6B and C). Clearly, this was due to the fact that the viral capsid 369 
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protein was degraded by gamma irradiation. At 22.4kGy treatment dose, we failed to detect any 370 
small round structured virions (Fig.6D), suggesting that virus particles were completely 371 
disrupted. There were some debris materials observed by EM, which perhaps was the degraded 372 
viral protein or mixture of degraded protein and RNA. For VSV, the virion is a bullet-shaped 373 
particle that is approximately 70 nm in diameter and 140 nm in length (Fig. 6E). After 2.8kGy 374 
treatment, VSV exhibited some morphological changes (Fig. 6F). Some virions became rounder 375 
and more ambiguous rather than the traditional bullet-shaped virions (Fig. 6F). In the 5.6kGy 376 
treated sample, less intact virions were observed. A large number of VSV virions were damaged 377 
and thus did not retain their original geometry (Fig. 6G). The viral envelope was not uniform and 378 
less defined. After 22.4kGy treatment, there was no intact bullet-shaped VSV particle observed 379 
under EM. Instead, a large concentration of damaged viruses clumped together (Fig. 6H). These 380 
clumped materials contained a few particles with severe damage and physical distortions. The 381 
viral envelopes were lost and viral N-RNA complex was spilling out of the damaged particles. 382 
Taken together, these results demonstrated that gamma irradiation damaged virus particles which 383 
in turn resulted in the inactivation of the viruses.  384 
 385 
Gamma irradiation degrades viral genomic RNA. MNV-1 is a positive-sense RNA virus 386 
whereas VSV is a non-segmented negative sense RNA virus. It would be lethal to the virus if 387 
viral RNA genome becomes damaged and/or degraded.  Briefly, highly purified MNV-1 and 388 
VSV were treated with gamma irradiation at three doses: 2.8, 5.6, and 22.4kGy. After treatment, 389 
RNA was extracted from each sample followed by RT-PCR to amplify the MNV-1 VP1 and 390 
VSV N gene, and the products were visualized by gel electrophoresis on 1% agarose gel. As 391 
shown in Fig.7A, the VP1 gene was amplified in RNA samples extracted from MNV-1 treated 392 
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by 2.8 and 5.6kGy irradiation doses although the abundance of VP1 gene decreased compared 393 
with the untreated controls. This was not surprising since there were significant amounts of virus 394 
survivors at both doses.  However, VP1 gene was not detectable in RNA sample from MNV-1 395 
stock treated by 22.4kGy irradiation in which MNV-1 was completely inactivated (Fig.7B), 396 
suggesting that MNV-1 genomic RNA was completely degraded after this dosage of irradiation 397 
exposure. Similarly, the amount of VSV N gene decreased when VSV was treated by 2.8 and 398 
5.6kGy irradiation (Fig.7C). Interestingly, a significant amount of VSV N gene was still detected 399 
in RNA sample from the VSV that was treated for 22.4kGy (Fig.7D).  It should be emphasized 400 
that VSV was completely inactivated at dose of 16.8 kGy (Fig.2). Since VSV genomic RNA was 401 
completely encapsidated by N protein, intact RNA may still present if N protein was not 402 
completely degraded. Indeed, approximately 25% of VSV N protein remained after 22.4 kGy 403 
treatment (Fig.4D). Therefore, VSV genome was still detectable by RT-PCR at this irradiation 404 
dose.  405 
           Next, we directly treated the viral genomic RNA by gamma irradiation. Briefly, viral 406 
genomic RNA was extracted from MNV-1 and VSV, and treated by three irradiation doses (2.8, 407 
5.6, and 11.2 kGy), followed by RT-PCR. At dose of 5.6 and 11.2 kGy, MNV-1 and VSV 408 
genomic RNA was undetectable by RT-PCR, respectively (data not shown). Taken together, 409 
these data demonstrated that gamma irradiation degraded viral genomic RNA.  410 
 411 
Gamma irradiation damages human norovirus virus-like particles (VLPs). Unfortunately, 412 
the study of the survival of human norovirus is hampered because it cannot be grown in cell 413 
culture systems (19). However, it is known that expression of human norovirus VP1 protein in 414 
insect cells results in self-assembly of VLPs that are structurally and antigenically identical to 415 
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native virions (6, 14, 30). Therefore, VLPs have been used as a tool to understand the biology of 416 
human norovirus (6. 14, 30). In fact, our above experiments demonstrated that the disruption of 417 
viral proteins and structure is one of the mechanisms of virus inactivation. Thus, we wanted to 418 
demonstrate the sensitivity of human norovirus VLPs to gamma irradiation. Briefly, the capsid 419 
gene VP1 of human norovirus strain HS66 was cloned into the baculovirus expression system, 420 
expressed in insect cells, and the VLPs were purified as described in Materials and Methods. The 421 
purified VLPs were negatively stained with ammonium molybdate, and analyzed by EM. As 422 
shown in Fig. 8A, the expressed VP1 protein formed small round structured particles which were 423 
identical to native human norovirus virions. Consistent with previous observations (6), two sizes 424 
of particles were found in EM analysis (Fig.8A). The size of the larger particles was between 30-425 
38 nm, and the smaller size was between 18-20 nm. To determine whether gamma irradiation 426 
damages the capsid, human norovirus VLPs were treated at three doses of irradiation. At a dose 427 
of 2.8 kGy, VLPs were clumped together and the morphology of VLPs was altered (Fig.8B). At 428 
a dose of 5.6 kGy, we observed a large concentration of protein debris and the structure of VLPs 429 
disappeared (Fig.8C). After 22.4kGy irradiation, we could not find any small spherical structured 430 
VLPs (Fig.8D), suggesting that VLPs were completely disrupted by gamma irradiation. 431 
            To demonstrate whether gamma irradiation degrades the capsid protein, the irradiated 432 
VLPs were analyzed by SDS-PAGE. For the untreated control, two protein bands with molecular 433 
weights of 58 and 55 kDa were observed (Fig.9A, lane 2). The 58kDa protein represented the 434 
native full-length VP1 protein and the 55 kDa protein was the cleaved form of VP1 protein 435 
(cVP1). This is consistent with the previous observation that baculovirus expressed VP1 is 436 
cleaved in insect cells (6, 30). After irradiation, the abundance of both protein bands was 437 
significantly diminished. Approximately 40% and 25% of human norovirus VP1 protein 438 
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remained after treatment at doses of 2.8 and 5.8 kGy (Fig.9A, lanes 2-3), and VP1 protein was 439 
not visualized at all after 22.4 kGy of irradiation (Fig.9A, lane 4). For MNV-1 VP1 protein, 50% 440 
and 30% VP1 remained after 2.8 and 5.8 kGy treatment. Furthermore, similar to MNV-1 VP1, 441 
the remaining human norovirus VP1 from irradiation still reacted with the polyclonal antibody 442 
(Fig.9B), suggesting that the undegraded protein was still antigenic. Fig. 9C showed the direct 443 
comparison of the stability of the capsid proteins of MNV-1 and human norovirus by gamma 444 
irradiation. Indeed, there was no significant difference between these two capsid proteins 445 
(P>0.05). Therefore, it seems that the irradiation dose that degraded MNV-1 VP1 may be 446 
sufficient to degrade human norovirus VP1.  447 
 448 
 449 
Discussion 450 
 451 
            Irradiation was patented for food preservation in 1905 in France. Since then, irradiation 452 
has been found as an effective food processing technology to eliminate bacteria, insects, fungi, 453 
and pests, and poses no significant risks to human health or the environment (5, 17, 34, 45, 59). 454 
However, the feasibility of gamma irradiation to eliminate viruses in foods is relatively less 455 
understood. In this study, we found that MNV-1, a human norovirus surrogate, is resistant to 456 
gamma irradiation. Only 1.7-2.4 logs virus reduction was observed in fresh produce samples at 457 
irradiation dose of 5.6 kGy.  Although VSV, an enveloped virus, is more susceptible than MNV-458 
1, only 3.3 log reductions were achieved at irradiation dose of 5.6 kGy in DMEM. Overall, 459 
viruses are much more resistant to irradiation than bacterial pathogens. Furthermore, we found 460 
that gamma irradiation degraded viral structural proteins, genetic materials, and damaged viral 461 
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particles which resulted in viral inactivation. Although gamma irradiation seems impractical to 462 
eliminate the virus contaminants in fresh produce by the FDA approved irradiation dose limits, 463 
this technology may be practical to inactivate viruses in other foods and to sterilize medical 464 
devices, ophthalmic solutions, pharmaceuticals, tissue culture sera, animal waste, and municipal 465 
sewage (17, 28, 29, 55, 57, 58).  466 
 467 
Gamma irradiation is not effective in eliminating human norovirus surrogate in fresh 468 
produce. A large amount of outbreak data showed that fresh produce has become one of the 469 
major vehicles of transmitting foodborne viruses, particularly human norovirus (2, 8, 26, 39, 53). 470 
Recent evidence showed that human norovirus not only tightly binds to fresh produce but also 471 
can become internalized (50, 61, 62). Traditional sanitization strategy is thus not effective in 472 
removing human norovirus from produce, particularly for those internalized virions. To improve 473 
the safety of fresh produce, the FDA has approved food irradiation up to dose of 4 kGy to 474 
inactivate bacterial pathogens.  It has been demonstrated that irradiation dose of 4-5 kGy almost 475 
completely inactivated major foodborne bacterial pathogens such as Escherichia coli O157:H7, 476 
Staphylococcus aureus, Listeria monocytogenes, Salmonella typhimurium, and mycotoxin 477 
producing Aspergillus spp. and Fusarium spp.(5, 17, 34, 45, 52, 59).  478 
           Our initial objective was to determine whether foodborne viruses can be inactivated at the 479 
approved irradiation dose. Unfortunately, according to our results, a 5.6kGy dose only eliminated 480 
MNV-1 in a range between 2.2-2.4 logs in the produce samples. Thus, the irradiation dose that 481 
normally would eliminate all pathogenic bacteria would not be sufficient to inactivate the 482 
norovirus surrogate. Previously, gamma irradiation of other two human norovirus surrogates, 483 
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feline calicivirus (FCV) and canine calicivirus (CaCV) has been reported (16). Surprisingly, a 3 484 
log virus reduction was observed by a very low dose of gamma irradiation (0.5kGy for FCV and 485 
0.3 kGy for CaCV) (16). Based on our results, MNV-1 is much more resistant than FCV and 486 
CaCV to gamma irradiation.  Irradiation of other food and waterborne viruses such as hepatitis A 487 
virus (HAV) (9), rotavirus (41), and poliovirus (27), has been reported.  It was found that the D10 488 
values (dose required to reduce infectivity by 1 log 10) for HAV in lettuce and strawberries were 489 
2.72+0.05 and 2.97+0.18 kGy, respectively (9), while the D10 value for gamma irradiating HAV 490 
in clams and oysters was 2 kGy (41).  It was also reported that D10 value for rotavirus required 491 
2.4 kGy (41).  Poliovirus inoculated to fish fillets required a dose of 6 kGy to achieve a 2-log 492 
reduction (27). Overall, major food and waterborne viruses are highly resistant to gamma 493 
irradiation. It seems impractical to utilize gamma irradiation to target viruses in fresh produce for 494 
the food processing industry at the approved doses. However, it is possible that food irradiation 495 
can be used for inactivating viruses in other food products. According to FDA Regulations 21 496 
CFR 179.26, a medium dose of irradiation (up to 10kGy) can be used for killing pathogenic and 497 
spoilage microorganisms within fresh fish, mushrooms, and frozen poultry. Medium dose 498 
irradiation is also employed for reducing the cooking time of dehydrated vegetables and 499 
extending the shelf life of food products. High dose (10-50kGy) irradiation is reserved for 500 
sterilization of spices, herbs, seasonings, meats and other prepared foods in combination with 501 
heat in order to inactivate enzymes.  502 
 503 
Mechanism of viral inactivation by gamma irradiation.   In early studies, it is thought that the 504 
damage of genetic material was the primary mechanism of microorganism inactivation by 505 
gamma irradiation (55, 57, 58). Gamma rays can directly “hit” the genetic material and indirectly 506 
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react with the nucleic acid via free radicals generated when gamma rays strike water molecules, 507 
which results in single or double strand breaks, cross linkage breaks, and nucleotide degradation. 508 
Consistent with this, the amount of MNV-1 VP1 gene decreased when the irradiation dose 509 
increased. For MNV-1, genomic RNA was undetectable when the virus was treated by 22.4kGy 510 
irradiation, suggesting that RNA was broken down. However, genetic material may not be 511 
completely degraded when a virus becomes inactivated. For example, VSV was completely 512 
killed after 16.8kGy dose, but a significant amount of VSV N gene was amplified even after 22.4 513 
kGy treatment (Fig.7D), a dose well beyond its inactivation limit. This was consistent with the 514 
fact that there was a significant amount of viral N protein remaining (Fig. 4D), which acted as a 515 
shield for the genetic material. It is also possible that RNA damage from irradiation was 516 
fortuitously not in the segment that was amplified in RT-PCR. 517 
          In addition to RNA degradation, we found that gamma irradiation also damaged virion 518 
structure and viral proteins. The number of intact virus particles and the concentration of viral 519 
proteins gradually decreased when gamma irradiation dose increased. The damage caused by 520 
gamma irradiation included breaking the viral envelope, disrupting the viral capsid, and 521 
physically distorting virion geometry. Gamma irradiation may not only disrupt the covalent 522 
bonds but also non-covalent interactions such as: hydrogen bonds, ionic bonds, van der Waals 523 
forces, and hydrophobic interactions, which are responsible for the secondary, tertiary, and 524 
quaternary structure of a protein. The full-length viral proteins were physically eroded without 525 
observation of intermediate products such as small peptides or protein fragments. This suggested 526 
that gamma irradiation not only disrupted quaternary and tertiary structure of a protein but also 527 
broke down secondary structure and primary amino acid sequences. Although virus inactivation 528 
is essentially a one-hit event, some viral proteins may entail many more hits at high gamma 529 
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irradiation doses. It was likely that these peptides, fragments, or amino acids were too small to be 530 
resolved by SDS-PAGE. Interestingly, the remaining viral proteins after 2.8 and 5.6 kGy of 531 
irradiation still reacted with antibody, suggesting that these proteins retained correct primary 532 
amino acid sequences. Previously, it was shown that UV irradiation affected the functions of the 533 
capsid proteins of HAV and FCV (46, 47). It will be interesting to determine whether UV also 534 
affects the integrity of virion structure.  535 
            We found that VSV was much more sensitive to gamma irradiation than MNV-1. There 536 
may be many factors contributing to irradiation sensitivity. First, the genome size of VSV (11 537 
kb) is larger than that of MNV-1 (7.7 kb). Indeed, early studies suggest there is an inverse 538 
relationship between inactivation dose and viral genome size (55, 57, 58). Second, enveloped 539 
viruses are likely more sensitive to gamma irradiation since the envelope may be easily damaged 540 
by irradiation. Third, VSV is structurally more complicated than that of MNV-1. VSV possesses 541 
five structural proteins, and damage of any of these structural proteins would be lethal to the 542 
virus. Finally, the size of virus particle may also contribute to the irradiation sensitivity. Larger 543 
particles would more likely to be hit by gamma rays due to the larger exposed surface area.  544 
           A clearer understanding of the mechanism of viral inactivation would also guide us to 545 
properly use gamma irradiation processing. Prior to our study, it is thought that damage of viral 546 
genetic material is the major target for virus inactivation (28, 29, 55, 57, 58). Therefore, gamma 547 
irradiation is widely used as means to prepare inactivated viral vaccines (12, 42). However, our 548 
mechanistic studies strongly suggest that gamma irradiation is not an ideal tool for preparing 549 
inactivated vaccines. First of all, a low dose of gamma irradiation is not able to completely 550 
inactivate the viruses, which will compromise the safety of the vaccine. More importantly, a high 551 
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dose of gamma irradiation disrupts the structure of virus particle and physically reduces total 552 
viral proteins including the immunogenic antigens (such as MNV-1 VP1 and VSV G) which are 553 
responsible for triggering an effective immune response. Thus, the efficacy of the vaccine would 554 
likely be impaired because the antigens would be damaged or severely diminished.  555 
 556 
Stability of the capsid proteins of MNV-1 and human norovirus to gamma irradiation. 557 
Because human norovirus cannot be grown in cell culture systems (19), no survival data are 558 
currently available for this important pathogen that has dramatic impacts on food safety and 559 
public health. Using human norovirus VLPs as a model, we demonstrated that the capsid protein 560 
of human norovirus was degraded by gamma irradiation. For calicivirus, it is widely accepted 561 
that VLPs are structurally, morphologically, and antigenically identical to native virion (6, 7, 14, 562 
30, 49). Three-dimension structure imaging revealed that human norovirus VLPs are composed 563 
of 90 dimers of the capsid protein, each of which forms an arch-like capsomere (14, 49). Such a 564 
structure is highly stable and thus can protect genomic RNA. For MNV-1, there was 50% and 565 
30% of VP1 protein remaining after 2.8 and 5.6 kGy of irradiation, respectively. However, there 566 
was 40% and 25% of human norovirus VP1 remaining after 2.8 and 5.6 kGy of irradiation, 567 
respectively. Similar to MNV-1, human norovirus VLPs were completely degraded at 22.4 kGy 568 
of irradiation. This suggests that the capsid proteins of human norovirus and MNV-1 may have 569 
an equivalent stability by gamma irradiation. EM analysis showed that gamma irradiation altered 570 
the morphology of VLPs which resulted in the disruption of VLPs. Although our study was 571 
based on human norovirus VLPs, it is the first evidence that the degradation kinetics of human 572 
norovirus capsid by gamma irradiation is similar to that of MNV-1. It is worthy to emphasize 573 
that human norovirus also encodes a minor capsid protein, VP2, a 18-kDa protein that plays an 574 
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important role in stabilizing the major capsid protein (VP1) by preventing the virus particle from 575 
degradation and disassembly (7). The native human norovirus possesses both VP1 and VP2, 576 
which is likely more stable than VLPs that only contain VP1 alone. Taking account of this factor, 577 
it is possible that human norovirus may be even more stable than MNV-1 to gamma irradiation.  578 
           In summary, we demonstrated that human norovirus surrogate is resistant to gamma 579 
irradiation. We provided first evidence that the capsid of human norovirus has an equivalent 580 
stability compared to its surrogate. Furthermore, we provided new mechanistic insights to viral 581 
inactivation by gamma irradiation. A better understanding of mechanism of viral inactivation 582 
will guide the proper application of irradiation in industry.  583 
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Figure legend 773 
FIG. 1. Gamma irradiation of MNV-1 in fresh produce and cell culture medium. MNV-1 774 
stock (108 PFU/ml) solutions were inoculated into spinach, lettuce, strawberry, and DMEM to 775 
achieve an inoculation level of 107 PFU/g  or 107 PFU/ ml. Prepared samples were irradiated up 776 
to 22.4 kGy and were  stomached for 2 min. Survival plot was determined by plaque assays. Data 777 
points were averages of three replicates. Error bars represent ± 1 standard deviation. 778 
 779 
FIG. 2. Comparison of the sensitivity of MNV-1 and VSV to gamma irradiation. MNV-1 780 
stock (108 PFU/ml) and VSV stock (109 PFU/ml) were inoculated in DMEM and exposed to 781 
irradiation up to 22.4kGy. Survival plot was determined by plaque assays. Data points were 782 
averages of three replicates. Error bars represent ± 1 standard deviation. 783 
 784 
FIG.3. Stability of MNV-1 and VSV in different buffers treated by gamma irradiation.  785 
MNV-1 and VSV stocks were inoculated into four different buffers (water, PBS, DMEM, and 786 
DMEM plus 10% FBS) at final concentration of 107 and 108 PFU/ml, respectively.  The samples 787 
were exposed to 2.8 and 5.6 kGy of irradiation. Virus survivors were determined by plaque 788 
assays. Data points were averages of three replicates.  (A) Stability of MNV-1 in different buffer. 789 
(B) Stability of VSV in different buffer. The inactivation kinetic of VSV in water and PBS is 790 
indistinguishable.  791 
 792 
FIG. 4. Gamma irradiation degrades MNV-1 and VSV structural proteins. (A) SDS-PAGE 793 
analysis of purified MNV-1 irradiated at 2.8kGy and 5.6kGy. Total viral proteins were analyzed 794 
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by 12% SDS-PAGE followed by commassie staining. VP1 = MNV-1 capsid protein. (B) SDS-795 
PAGE analysis of purified MNV-1 irradiated at 22.4 kGy. No VP1 protein was present after the 796 
treatment. (C) SDS-PAGE analysis of purified VSV irradiated at 2.8kGy and 5.6kGy. Five 797 
structural proteins of VSV, L, G, P, N and M proteins were visualized after commassie blue 798 
staining. (D) SDS-PAGE analysis of purified VSV irradiated at 22.4 kGy. Only VSV N and M 799 
proteins were visualized after the treatment. 800 
 801 
FIG. 5. Western blot analysis of MNV-1 capsid protein and VSV G protein after gamma 802 
irradiation. (A) Western blot analysis of MNV-1 capsid protein.  Purified MNV-1 was 803 
irradiated at doses of 2.8 and 5.6 kGy. Total proteins were separated by SDS-PAGE and 804 
subjected to Western blot using rabbit anti-MNV VP1 polyclonal antibody.  (B) Western blot 805 
analysis of VSV G protein. Purified VSV was irradiated at doses of 2.8 and 5.6 kGy. Total 806 
proteins were separated by SDS-PAGE and subjected to Western blot using monoclonal antibody 807 
against VSV G protein.  808 
 809 
FIG. 6. Gamma irradiation damages MNV-1 and VSV.  Purified MNV-1 and VSV were 810 
irradiated at doses of 2.8, 5.6 and 22.4 kGy. Treated and un-treated virus particles were 811 
negatively stained with 1% ammonium molybdate and visualized by transmission electron 812 
microscope.  (A) Untreated MNV-1 virion. (B) MNV-1 particles treated by 2.8 kGy. (C) MNV-1 813 
particles treated by 5.6 kGy. (D) MNV-1 particles treated by 22.4 kGy. (E) Untreated VSV 814 
virion. (F) VSV particles treated by 2.8 kGy. (G) VSV particles treated by 5.6 kGy. (H) VSV 815 
particles treated by 22.4 kGy. 816 
 817 
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FIG. 7. RT-PCR analysis of MNV-1 and VSV after gamma irradiation. (A) Detection of 818 
VP1 gene from MNV-1 irradiated at 2.8 and 5.6kGy. Viral genomic RNA was extracted from 819 
either treated or untreated MNV-1. The VP1 gene of MNV-1 was amplified by one-step RT-820 
PCR, and PCR products were visualized on 1% agarose gel electrophoresis. (B) Detection of 821 
VP1 gene from MNV-1 irradiated at 22.4kGy. (C) Detection of N gene from VSV irradiated at 822 
2.8 and 5.6 kGy. Viral genomic RNA was extracted from either treated or untreated VSV. The 823 
VSV N gene was amplified by one-step RT-PCR. (D) Detection of N gene from VSV irradiated 824 
at 22.4kGy. 825 
 826 
FIG. 8. Gamma irradiation damages human norovirus VLPs. Human norovirus VLPs were 827 
expressed and purified from insect cells using baculovirus expression system. The VLPs were 828 
irradiated at three doses, 2.8, 5.6, and 22.4 kGy. Treated and un-treated VLPs were negatively 829 
stained with 1% ammonium molybdate and visualized by transmission electron microscope. (A) 830 
Untreated human norovirus VLPs. (B) VLPs treated by 2.8 kGy. (C) VLPs treated by 5.6 kGy. 831 
(D) VLPs treated by 22.4 kGy. 832 
 833 
FIG.9. Gamma irradiation degrades the capsid protein of human norovirus. (A) 834 
Visualization of human norovirus capsid protein by 12% SDS-PAGE. The purified VLPs were 835 
irradiated at 2.8, 5.6 and 22.4 kGy. Total viral proteins were analyzed by 12% SDS-PAGE 836 
followed by commassie staining. VP1 = human norovirus capsid protein. cVP1= cleaved VP1 837 
protein. (B) Western blot analysis of human norovirus VP1 protein. Identical samples from panel 838 
A were separated by SDS-PAGE and subjected to Western blot using a polyclonal antibody 839 
against VP1 protein. (C) Comparison of the stability of the capsid proteins of MNV-1 and human 840 
36 
 
norovirus by gamma irradiation. Two µg of MNV-1 and human norovirus VLPs were treated at 841 
2.8, 5.6 and 22.4 kGy. Total proteins were separated by SDS-PAGE followed by commassie 842 
staining. The remaining proteins from gamma irradiation were quantified by ImageQuant TL 843 
software. Data points were averages of three replicates. 844 









